ADVERTISEMENT

Stay up to date every week with the european biotechnology newsletter.

✕

Instagram

This field is for validation purposes and should be left unchanged.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

Stay up to date every week with the european biotechnology newsletter.

Log in here to read the desired article.

Name

This field is for validation purposes and should be left unchanged.

Email(Required)

This field is hidden when viewing the form

EBcom NL

confirm list

This field is hidden when viewing the form

Consent

I agree to the privacy policy.

go to the article

go back to the homepage

Subscription
Newsletter
Advertise

Latest news
Background
Opinion
The Mag
Euro Biotech Guide
Market Place
Associations
Service
Events
Search
Menu Menu

ADVERTISEMENT

SPECIALS

Special Summer 2023

Euro BioFairs Compass

2nd half year 2023 more ➔

Page 3 of 31 23

LATEST NEWS

Suzhou, Jiangsu, China

Novartis bets up to $7.8B on Abogen’s mRNA autoim...

The Leadership Edit Thumbnail European Biotechnology

Pharming changes CEO, Evotec loses CSO and Nanobiot...

arthritis pain fingers

Amplio’s Phase 1b data hint at better first-line...

ADVERTISEMENT

MAGAZINE

1 / 4

EBM 3.2026 Autumn_cover

The autumn issue of European Biotechnology magazine asks what happens when biotech leaves Earth. Our cover story explores how microgravity could help researchers study disease, improve drug formulations … more ➔

2 / 4

The summer issue of European Biotechnology Magazine showcases the latest developments in drug delivery and RNA technologies. This issue features a list of eight venture capital firms to watch in 2026. … more ➔

3 / 4

The Spring 2026 issue of European Biotechnology Magazine presents a list of start-ups to watch in 2026 and explores other fascinating topics such as: Can biotechnology finally fix infertility? Can … more ➔

4 / 4

EB425_Cover

Europe is losing much of its expertise in deep tech and life sciences to the US. To prevent another generation of innovation from being lost, Europe must close the funding gaps. more ➔

SPONSORED PUBLICATION

1 / 3

Professor Jacob George, Chief Medical and Scientific Officer at the MHRA presenting his keynote speech at Phacilitate Advanced Therapies Europe, 2026

Cell & Gene Therapy

Europe’s CGT advantage at risk

Industry leaders at Advanced Therapies Europe 2026 warned that Europe must tackle barriers across commercialisation, regulation, reimbursement, manufacturing and patient access to retain its global … more ➔

2 / 3

Ute Kilger

intellectual property

G 1/25: Form over function and how expensive is it?

In proceedings before the European Patent Office (EPO), applicants are required to „adapt“ the description to the claims of a patent application once the claims are deemed allowable. The adaptation … more ➔

3 / 3

Ponchi Kantt-Neaz, Global Executive Business Director 3PBIOVIAN

Commercial Strategy

3PBIOVIAN appoints Ponchi Kantt-Neaz as Global Executive Business Director

The appointment of Ponchi marking an important milestone in the company’s global commercial strategy and further strengthening its commercial leadership as the company continues to expand its presence … more ➔

newsletter_link

Knowbio GmbH

Link to LinkedIn
Link to Instagram

Contact
Imprint
Privacy policy